The multifaceted actions of VIP make it a promising target for therapeutic applications in various conditions, such as gastrointestinal disorders, inflammatory diseases, and neurological conditions
Additionally, integrating the injection into a daily routine can serve as a natural reminder
RECOMMENDED SESSIONS Weekly injections are typically recommended for the best results
Both agents promoted weight loss (SGLT2i: standardized mean difference -0.59
Conclusion : Semaglutide, initially developed for the management of type 2 diabetes and obesity, offers a wide range of health benefits beyond its primary indications
Narayana, President, SEAR Pharm Forum, President Indian Pharmaceutical Association - India Facilitator: -Manisha Shridhar, Regional Advisor, IPR, Trade&Health, WHO-SEARO - India Speakers: - Manjiri Gharat, FIP Vice-President, Vice-President of Indian Pharmaceutical Association (IPA) and Chairperson of IPA Comm.Ph.Division